GlassScriptPhysician profile
Vito A Mercurio
NPI 1518923135
$1,681.21
in general payments reported to CMS, 2019-2025
18 companies · $592 in 2025
The $592 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2021: $208 · 2022: $352 · 2023: $282 · 2024: $104 · 2025: $592.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $979.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $978.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $451.72 | 2021-2025 | Jardiance |
| Medtronic, INC. | $347.19 | 2021-2025 | Azure Xt Dr Mri Surescan, Cobalt Dr Mri Surescan, Linq II |
| Boston Scientific Corporation | $176.49 | 2022-2025 | Watchman Flx |
| Abbott Laboratories | $118.26 | 2023-2024 | Mitraclip |
| Pfizer INC. | $95.47 | 2019 | |
| Merck Sharp & Dohme LLC | $79.48 | 2025 | Verquvo, Capvaxive |
| Alnylam Pharmaceuticals INC. | $71.73 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $57.42 | 2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $54.09 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $46.58 | 2019 | |
| Amgen INC. | $38.94 | 2025 | Repatha |
| Inspire Medical Systems, INC. | $37.18 | 2025 | Inspire |
| Tactile Systems Technology INC | $24.04 | 2025 | Flexitouch Plus, Nimbl |
| Edwards Lifesciences Corporation | $19.10 | 2024 | Sapien 3 Ultra Resilia |
| Regeneron Healthcare Solutions, INC. | $18.28 | 2025 | Evkeeza |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.42 | 2021 | |
| Heartflow, INC. | $15.26 | 2025 | |
| Novo Nordisk INC | $14.56 | 2025 | Ozempic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vito Mercurio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.